Efficacy, Tolerability, and Safety of DFN-15
Public ClinicalTrials.gov record NCT03009019. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Efficacy, Tolerability, and Safety Study of DFN-15 in Episodic Migraine With or Without Aura
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Efficacy, Tolerability, and Safety of DFN-15 in episodic migraine with or without aura, being conducted at multiple centers in the United States
Study identification
- NCT ID
- NCT03009019
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 631 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 2016 (Type not available)
- Primary completion
- Nov 2017 (Actual)
- Completion
- May 2019 (Actual)
- Last update posted
- Jan 10, 2023
2016 – 2019
United States locations
- U.S. sites
- 43
- U.S. states
- 28
- U.S. cities
- 42
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Site 609 | Birmingham | Alabama | 35205 | — |
| Site 640 | Mobile | Alabama | 36608 | — |
| Site 622 | Tucson | Arizona | 85745 | — |
| Site 616 | Hot Springs | Arkansas | 71901 | — |
| Site 637 | Huntington Beach | California | 92647 | — |
| Site 615 | Oakland | California | 94607 | — |
| Site 646 | San Diego | California | 92108 | — |
| Site 619 | San Francisco | California | 94102 | — |
| Site 624 | San Marcos | California | 92078 | — |
| Site 631 | Littleton | Colorado | 80127 | — |
| Site 603 | Miami | Florida | 33176 | — |
| Site 641 | Orange City | Florida | 32763 | — |
| Site 629 | Orlando | Florida | 32801 | — |
| Site 601 | West Palm Beach | Florida | 33409 | — |
| Site 625 | Decatur | Georgia | 30034 | — |
| Site 630 | Sandy Springs | Georgia | 30328 | — |
| Site 642 | Meridian | Idaho | 83642 | — |
| Site 604 | Blue Island | Illinois | 60406 | — |
| Site 602 | Louisville | Kentucky | 40213 | — |
| Site 644 | New Orleans | Louisiana | 70115 | — |
| Site 610 | New Orleans | Louisiana | 70124 | — |
| Site 634 | Ann Arbor | Michigan | 48104 | — |
| Site 623 | Edina | Minnesota | 55435 | — |
| Site 638 | City of Saint Peters | Missouri | 63303 | — |
| Site 606 | Missoula | Montana | 59808 | — |
| Site 613 | Omaha | Nebraska | 68134 | — |
| Site 647 | Lebanon | New Hampshire | 03756 | — |
| Site 618 | Nashua | New Hampshire | 03060 | — |
| Site 636 | Albuquerque | New Mexico | 87102 | — |
| Site 645 | Brooklyn | New York | 11229 | — |
| Site 608 | Rochester | New York | 14609 | — |
| Site 620 | High Point | North Carolina | 27262 | — |
| Site 643 | Mooresville | North Carolina | 28117 | — |
| Site 626 | Fargo | North Dakota | 58103 | — |
| Site 628 | Cleveland | Ohio | 44122 | — |
| Site 614 | Warwick | Rhode Island | 02886 | — |
| Site 639 | Mt. Pleasant | South Carolina | 29464 | — |
| Site 612 | Dakota Dunes | South Dakota | 57049 | — |
| Site 627 | Austin | Texas | 78745 | — |
| Site 611 | Dallas | Texas | 75231 | — |
| Site 632 | San Antonio | Texas | 78240 | — |
| Site 621 | Taylorsville | Utah | 84123 | — |
| Site 635 | Richmond | Virginia | 23294 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03009019, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 10, 2023 · Synced Oct 28, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03009019 live on ClinicalTrials.gov.